semaglutide cognitive effects Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review | Pharmaceutical Research Frontiers | Effect and mechanism

Thats different

However, our results support the conclusion that tirzepatide 15 mg, followed by tirzepatide 10 mg, had better efficacy and a similar safety profile compared with other GLP-1 RAs

Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP1-RA) that is administered subcutaneously once weekly

The drugs can disturb or cut off blood flow to the optic nerve

In addition, the researchers set secondary endpoints of change in 6-minute walk distance, and change in log transformed Those in the semaglutide group had a larger reduction in heart failure symptoms, with a mean improvement of 13.7 points on the KCCQ-CSS, compared with 6.4 points for the placebo group